Mercado de oxigenación por membrana extracorpórea: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001219
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 162
Buy Now

El mercado mundial de oxigenación por membrana extracorpórea se valoró en 546,73 millones de dólares en 2021 y se prevé que alcance los 677,64 millones de dólares en 2028. Se estima que el mercado crecerá a una tasa compuesta anual del 3,1% durante 2022-2028. .

La oxigenación por membrana extracorpórea (oxigenación por membrana extracorpórea) es un tratamiento que se utiliza para la circulación sanguínea a través de un pulmón artificial. El sistema ayuda a proporcionar una ruta de derivación corazón-pulmón fuera del cuerpo. Esto también brinda apoyo a los pacientes que necesitan un trasplante de pulmón. El crecimiento del mercado de oxigenación por membrana extracorpórea se atribuye a la creciente prevalencia de enfermedades cardiovasculares e insuficiencias respiratorias y a la creciente adopción de la oxigenación por membrana extracorpórea en los procedimientos de trasplante de pulmón. Sin embargo, las complicaciones asociadas con la oxigenación por membrana extracorpórea obstaculizan el crecimiento del mercado.

Perspectivas estratégicas

regiones lucrativas en el mercado de oxigenación por membrana extracorpórea

 < /p>

Perspectivas del mercado

La creciente adopción de la oxigenación por membrana extracorpórea en procedimientos de trasplante de pulmón impulsa el crecimiento del mercado de oxigenación por membrana extracorpórea

El trasplante de pulmón es una vida -Opción de tratamiento ahorradora para pacientes que padecen enfermedades pulmonares terminales, como EPOC, fibrosis pulmonar idiopática (FPI) y fibrosis quística, para mejorar la calidad de vida. La oxigenación por membrana extracorpórea es una herramienta versátil utilizada en todas las fases del trasplante de pulmón, como el preoperatorio, intraoperatorio y postoperatorio. Actúa como puente para el paciente sometido a un trasplante de pulmón. Por lo tanto, la adopción de la oxigenación por membrana extracorpórea durante el trasplante de pulmón está creciendo rápidamente para tratar a pacientes con enfermedades pulmonares potencialmente mortales. Según el Registro Científico de Receptores de Trasplantes (SRTR), cada año se realizan alrededor de 4.600 trasplantes de pulmón en todo el mundo, de los cuales el 55% se realizaron en América del Norte. Según la misma fuente, ~2759 pacientes se sometieron a un trasplante de pulmón y ~3243 pacientes se agregaron a la lista de espera de trasplante de pulmón en los EE. UU. La disfunción primaria del injerto (PGD) es la principal causa de muerte después de un trasplante de pulmón. Por tanto, la oxigenación por membrana extracorpórea se utiliza en penúltimo lugar en el tratamiento del PGD después del trasplante de pulmón. Según National Library Medicine (NLM), en 2022, la incidencia general de PGD es del 30%, en el que los factores de riesgo incluyen isquemia pulmonar preoperatoria del donante, adquisición de órganos, técnicas de preservación e implantación y reperfusión de órganos intraoperatoria. Por lo tanto, la demanda de equipos de oxigenación por membrana extracorpórea está creciendo para el tratamiento de pacientes que padecen PGD.

Información basada en la modalidad

El mercado global de oxigenación por membrana extracorpórea, según la modalidad, se segmenta en oxigenación por membrana extracorpórea venoarterial, oxigenación por membrana extracorpórea venovenosa y oxigenación por membrana extracorpórea arteriovenosa. El segmento de oxigenación por membrana extracorpórea venoarterial tuvo la mayor participación del mercado en 2021. Además, se prevé que el mismo segmento registre una CAGR más alta del 3,8% en el mercado durante el período de pronóstico. La oxigenación por membrana extracorpórea venoarterial (VA) apoya el corazón y los pulmones del paciente empujando la sangre a través del circuito sin pasar por el corazón del paciente. Este tipo de oxigenación por membrana extracorpórea extrae sangre de una vena grande y la devuelve a una arteria grande, lo que permite que la sangre rica en oxígeno circule por el cuerpo incluso si el corazón está demasiado débil para bombear. La oxigenación por membrana extracorpórea venoarterial (oxigenación por membrana extracorpórea VA) se ha aplicado ampliamente durante la última década. Es una opción terapéutica eficaz y valiosa en el shock cardiogénico refractario de diversas etiologías. Mostró resultados prometedores en el contexto específico del paro cardíaco intrahospitalario, y las tasas de supervivencia con buenos resultados neurológicos se reportan entre el 20% y el 40%.

Mercado de oxigenación por membrana extracorpórea, por modalidad: 2021 y 2028

Perspectivas basadas en grupos de edad

Según el grupo de edad, el mercado mundial de oxigenación por membrana extracorpórea es segmentado en adultos, pediatría y neonatos. El segmento de adultos tuvo la mayor participación del mercado en 2021 y se espera que registre una tasa compuesta anual del 3,7% durante 2022-2028. La oxigenación por membrana extracorpórea ayuda a los pacientes adultos que padecen insuficiencia cardíaca o respiratoria. Además, los recientes avances tecnológicos en los circuitos de oxigenación por membrana extracorpórea han llevado a una reducción en la tasa de problemas técnicos y complicaciones.

Oxigenación por membrana extracorpórea: oxigenación por membrana extracorpórea: Segmentación del mercado

El mercado de oxigenación por membrana extracorpórea se segmenta según la modalidad, la aplicación, el grupo de edad y la geografía. Según la modalidad, el mercado se segmenta en oxigenación por membrana extracorpórea venoarterial, oxigenación por membrana extracorpórea venoarterial , oxigenación por membrana extracorpórea arteriovenosa. Según la aplicación, el mercado de la oxigenación por membrana extracorpórea se divide en respiratorio y cardiología. En términos de usuario final, el mercado de oxigenación por membrana extracorpórea se segmenta en adultos, pediatría y recién nacidos. Por geografía, el mercado de oxigenación por membrana extracorpórea está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y el resto de Europa), Asia Pacífico (China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico), Oriente Medio y Asia. África (Emiratos Árabes Unidos, Arabia Saudita, África y el resto de Medio Oriente y África) y Sur y África. América Central (Brasil, Argentina y el resto de América Central y del Sur).

Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su huella global y sus carteras de productos para dominar el mercado extracorpóreo. Cuota de mercado de oxigenación por membrana. Además, los actores del mercado se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo. Se prevé que el mercado prosperará en los próximos años debido al desarrollo de nuevos productos innovadores por parte de los actores del mercado.

Perfiles de la empresa

  • Grupo Terumo
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Eurosets SRL
  • Getinge AB< /li>
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.

Who are the major players in market the extracorporeal membrane oxygenation market?

The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.

What are the restraining factors for the extracorporeal membrane oxygenation market across the country?

The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period

What are the driving factors for the extracorporeal membrane oxygenation market across the country?

Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.

What is the extracorporeal membrane oxygenation market?

Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.

Which region is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.

The List of Companies - Extracorporeal Membrane Oxygenation Market

  1. Terumo Group
  2. Medtronic Plc
  3. MicroPort Scientific Corporation
  4. LivaNova Plc
  5. Nipro Medical Corporation
  6. Eurosets S.R.L.
  7. Getinge AB
  8. Braile Biomedica
  9. Fresenius Medical Care AG & Co KGaA
  10. ABIOMED Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports